Return to content in this issue


Tolerance to SARS-CoV-2 mRNA vaccination in a patient with challenge-confirmed PEG 2000 allergy

Faihs V, Bent R, Darsow U, Biedermann T, Brockow K

Department of Dermatology and Allergy Biederstein, School of Medicine, Technical University of Munich, Munich, Germany 

J Investig Allergol Clin Immunol 2023; Vol. 33(2)
doi: 10.18176/jiaci.0829

Key words: SARS-CoV-2, COVID-19, Polyethylene glycol, mRNA vaccine, Anaphylaxis